DE69131903T2 - Klonierung hühner-anaemia-virus-dna - Google Patents

Klonierung hühner-anaemia-virus-dna

Info

Publication number
DE69131903T2
DE69131903T2 DE69131903T DE69131903T DE69131903T2 DE 69131903 T2 DE69131903 T2 DE 69131903T2 DE 69131903 T DE69131903 T DE 69131903T DE 69131903 T DE69131903 T DE 69131903T DE 69131903 T2 DE69131903 T2 DE 69131903T2
Authority
DE
Germany
Prior art keywords
cav
anaemia virus
virus dna
chicken anaemia
cloning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69131903T
Other languages
English (en)
Other versions
DE69131903D1 (de
Inventor
Mathieu Hubertus Maria Noteborn
Gerben Foppe De Boer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leadd BV
Original Assignee
Leadd BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leadd BV filed Critical Leadd BV
Publication of DE69131903D1 publication Critical patent/DE69131903D1/de
Application granted granted Critical
Publication of DE69131903T2 publication Critical patent/DE69131903T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
DE69131903T 1990-09-12 1991-09-11 Klonierung hühner-anaemia-virus-dna Expired - Lifetime DE69131903T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9002008A NL9002008A (nl) 1990-09-12 1990-09-12 Recombinant dna en rna en daarvan afgeleide produkten.
PCT/NL1991/000165 WO1992004446A1 (en) 1990-09-12 1991-09-11 Cloning of chicken anaemia dna

Publications (2)

Publication Number Publication Date
DE69131903D1 DE69131903D1 (de) 2000-02-17
DE69131903T2 true DE69131903T2 (de) 2000-07-20

Family

ID=19857669

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131903T Expired - Lifetime DE69131903T2 (de) 1990-09-12 1991-09-11 Klonierung hühner-anaemia-virus-dna

Country Status (21)

Country Link
US (6) US5491073A (de)
EP (2) EP0905246A1 (de)
JP (1) JP2846116B2 (de)
AT (1) ATE188739T1 (de)
AU (1) AU651999B2 (de)
CA (1) CA2091181C (de)
DE (1) DE69131903T2 (de)
DK (1) DK0548234T3 (de)
ES (1) ES2144399T3 (de)
GR (1) GR3033173T3 (de)
HR (1) HRP940668B1 (de)
HU (1) HU220102B (de)
IL (1) IL99435A (de)
MX (1) MX9101042A (de)
NL (1) NL9002008A (de)
RU (1) RU2146292C1 (de)
SI (1) SI9111508B (de)
UA (1) UA48936C2 (de)
WO (1) WO1992004446A1 (de)
YU (1) YU49095B (de)
ZA (1) ZA917065B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080234466A1 (en) * 1990-09-12 2008-09-25 Noteborn Mathieu H M Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
US6162461A (en) * 1990-09-12 2000-12-19 Leadd B.V. Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
US20030138443A1 (en) * 1993-03-08 2003-07-24 Noteborn Mathews H.M. Cloning of chicken anemia virus DNA
US20020061296A1 (en) * 2000-09-08 2002-05-23 Noteborn Mathieu H.M. Delivery method for the tumor specific apoptosis inducing activity of apoptin
NL9301272A (nl) * 1993-07-20 1995-02-16 Aesculaap Bv Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
EP0878546A1 (de) * 1997-04-15 1998-11-18 Leadd B.V. Genabgabe-Vehikel die das Apoptosis VP2 inducierendes Protein, und/oder Apoptin exprimiert
US5789567A (en) * 1994-07-06 1998-08-04 Cornell Research Foundation, Inc. Chicken infectious anemia virus vaccine
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
NZ309172A (en) * 1995-06-07 1999-11-29 Leadd B Neutralizing conformational epitopes of chicken anemia virus
US6127115A (en) * 1995-11-14 2000-10-03 Ragland; William L. Efficient method of detecting an infectious agent in blood
WO1999008108A1 (en) 1997-08-12 1999-02-18 Leadd B.V. Determining the transforming capability of agents
EP1064024A4 (de) * 1998-03-13 2005-04-06 Univ Georgia Res Found Impfstoffe gegen circovirus infektionen
PT1083224E (pt) * 1999-09-02 2007-03-30 Leadd Bv Proteína associada a apoptina
IL150134A0 (en) * 1999-12-10 2002-12-01 Leadd Bv Apoptin-associating protein
US6593134B1 (en) 2000-03-10 2003-07-15 Cornell Research Foundation, Inc. Method of propagating chicken infectious anemia virus
HU230236B1 (hu) * 2000-07-10 2015-10-28 Uni-Charm Corporation Takarítóeszköz
EP1199363A1 (de) * 2000-10-20 2002-04-24 Leadd B.V. Phosphorylationsmodifikationen von Apoptin
EP1436001A4 (de) * 2001-09-05 2006-01-11 Biomune Hühner-anämie-virus-vakzine aus zelllinie
US7566548B2 (en) * 2004-08-13 2009-07-28 University Of Massachusetts Methods for identifying therapeutic agents and for treating disease
CN102636646A (zh) * 2012-05-15 2012-08-15 扬州大学 快速检测禽白血病抗原的试纸条及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2042888B (en) 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS6032714A (ja) 1983-08-01 1985-02-19 Teijin Ltd 鼻腔粘膜に適用するための安定化された粉末状薬学的組成物
EP0188040B1 (de) 1985-01-11 1991-08-14 Abbott Laboratories Limited Feste Zubereitung mit langsamer Freisetzung
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5059587A (en) 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
GB8723846D0 (en) 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US5079005A (en) 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
AU633272B2 (en) * 1988-09-13 1993-01-28 Merial Viral nucleotide sequences
GB2237510B (en) 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
ZA918426B (en) 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic

Also Published As

Publication number Publication date
YU150891A (sh) 1995-10-24
US6238669B1 (en) 2001-05-29
HRP940668B1 (en) 2000-10-31
ATE188739T1 (de) 2000-01-15
HUT65974A (en) 1994-08-29
US5491073A (en) 1996-02-13
US5932476A (en) 1999-08-03
JPH06504195A (ja) 1994-05-19
US5958424A (en) 1999-09-28
JP2846116B2 (ja) 1999-01-13
SI9111508B (en) 2001-12-31
RU2146292C1 (ru) 2000-03-10
EP0548234A1 (de) 1993-06-30
DE69131903D1 (de) 2000-02-17
HU220102B (hu) 2001-10-28
CA2091181C (en) 2006-02-21
YU49095B (sh) 2003-12-31
HRP940668A2 (en) 1997-12-31
MX9101042A (es) 1992-08-10
IL99435A0 (en) 1992-08-18
US20020103336A1 (en) 2002-08-01
CA2091181A1 (en) 1992-03-13
EP0905246A1 (de) 1999-03-31
UA48936C2 (uk) 2002-09-16
AU8658091A (en) 1992-03-30
US6509446B2 (en) 2003-01-21
HU9300716D0 (en) 1993-06-28
SI9111508A (sl) 1998-10-31
NL9002008A (nl) 1992-04-01
WO1992004446A1 (en) 1992-03-19
US6319693B1 (en) 2001-11-20
ES2144399T3 (es) 2000-06-16
EP0548234B1 (de) 2000-01-12
GR3033173T3 (en) 2000-08-31
AU651999B2 (en) 1994-08-11
DK0548234T3 (da) 2000-06-19
IL99435A (en) 2006-10-31
ZA917065B (en) 1992-05-27

Similar Documents

Publication Publication Date Title
DE69131903D1 (de) Klonierung hühner-anaemia-virus-dna
DE69535061D1 (de) Virale nukleotidsequenz vr-2332 und nutzungsverfahren
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
DE3678016D1 (de) Rna-transformationsvektor.
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
ATE214095T1 (de) Verwendung einer exo-nukleotidprobe in der genklonierung
RU93005170A (ru) Нуклеиновые кислоты, применение нуклеиновых кислот, диагностические наборы, вакцины, клетки, белок, применение белка, антитела, применение антител
FI102768B1 (fi) Hybridi-DNA-molekyyli ja menetelmä fibronektiiniä sitovan proteiinin valmistamiseksi
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
ATE184052T1 (de) Gdf-1 und uog1 proteine
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
DE68927025T2 (de) HIV-2-Virusvarianten
ES545725A0 (es) Procedimiento para preparar peptidos de interferon
ATE100495T1 (de) Rekombinantes marek-krankheitsvirus, verfahren zu seiner herstellung, und vakzine.
AU8405798A (en) A swine hepatitis e virus and uses thereof
ATE99331T1 (de) Fusionsproteine und herstellung davon.
AU686000B2 (en) Infectious peritonitis vaccine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition